Fastest Growing Canadian Companies by Revenue — Health Care
Canadian companies ranked by year-over-year revenue growth.
Updated November 11, 2026200 companiesTotal market cap $619.4B
Showing 200 companies (CDRs hidden)
| Rank | Company | Symbol | Market Cap | Revenue (TTM) | Revenue Growth (YoY) |
|---|---|---|---|---|---|
| 1 | Axe Compute Inc. | AGPU:US | $78M | $3M | 119772.90% |
| 2 | Precision BioSciences Inc | DTIL:US | $369M | $45M | 37272.40% |
| 3 | 4D Molecular Therapeutics Inc | FDMT:US | $677M | $92M | 25106.70% |
| 4 | Septerna, Inc. Common Stock | SEPN:US | $2.3B | $99M | 22375.60% |
| 5 | Vir Biotechnology Inc | VIR:US | $2.3B | $303M | 19582.50% |
| 6 | Nakamoto Inc. | NAKA:US | $104M | $28M | 8680.10% |
| 7 | MeiraGTx Holdings PLC | MGTX:US | $911M | $398M | 8608.60% |
| 8 | Nurix Therapeutics Inc | NRIX:US | $1.8B | $702M | 8426.30% |
| 9 | Adagene Inc | ADAG:US | $134M | $9M | 7332.80% |
| 10 | Solana Company | HSDT:US | $126M | $12M | 5774.40% |
| 11 | Protagonist Therapeutics Inc | PTGX:US | $8.6B | $552M | 5723.60% |
| 12 | Connect Biopharma Holdings Ltd | CNTB:US | $46M | $3M | 5666.70% |
| 13 | NewAmsterdam Pharma Company N.V. Ordinary Shares | NAMS:US | $2.3B | $26M | 5406.90% |
| 14 | Alector Inc | ALEC:US | $366M | $173M | 4895.90% |
| 15 | Aethlon Medical Inc | AEMD:US | $9M | $574,245 | 4278.20% |
| 16 | Therma Bright Inc | THRM:V | $2M | $135,824 | 3771.40% |
| 17 | Aligos Therapeutics Inc | ALGS:US | $25M | $32M | 2778.50% |
| 18 | Abeona Therapeutics Inc | ABEO:US | $238M | $26M | 2745.00% |
| 19 | Precigen Inc | PGEN:US | $1.7B | $157M | 2437.60% |
| 20 | Cytokinetics Inc | CYTK:US | $7.5B | $113M | 2356.50% |
| 21 | HCW Biologics Inc | HCWB:US | $2M | $7M | 1969.70% |
| 22 | Liquidia Technologies Inc | LQDA:US | $4.3B | $451M | 1842.70% |
| 23 | Hyperion DeFi, Inc. | HYPD:US | $38M | $1M | 1559.50% |
| 24 | Pasithea Therapeutics Corp | KTTA:US | $19M | $486,559 | 1498.10% |
| 25 | Praxis Precision Medicines Inc | PRAX:US | $7.8B | $7M | 1349.10% |
| 26 | Crispr Therapeutics AG | CRSP:US | $4.9B | $25M | 1325.10% |
| 27 | AC Immune Ltd | ACIU:US | $222M | $18M | 1057.20% |
| 28 | Moolec Science SA Ordinary Shares | MLEC:US | $1M | $8M | 948.30% |
| 29 | Exicure Inc | XCUR:US | $6M | - | 928.00% |
| 30 | Rani Therapeutics Holdings Inc | RANI:US | $77M | $5M | 893.00% |
| 31 | KDA Group Inc | KDA:V | $12M | $419,129 | 791.20% |
| 32 | Bio Green Med Solution, Inc. | BGMS:US | $6M | $2M | 710.00% |
| 33 | Virax Biolabs Group Limited Ordinary Shares | VRAX:US | $1M | $12,423 | 684.90% |
| 34 | Immutep Ltd ADR | IMMP:US | $28M | $20M | 633.50% |
| 35 | Tonix Pharmaceuticals Holding Corp | TNXP:US | $81M | $29M | 577.90% |
| 36 | Bullfrog AI Holdings, Inc. Common Stock | BFRG:US | $10M | $298,798 | 547.60% |
| 37 | VistaGen Therapeutics Inc | VTGN:US | $7M | $3M | 504.90% |
| 38 | Dare Bioscience Inc | DARE:US | $13M | $1M | 499.60% |
| 39 | Kymera Therapeutics Inc | KYMR:US | $11.9B | $102M | 466.40% |
| 40 | Xencor Inc | XNCR:US | $2.9B | $200M | 454.90% |
| 41 | PAVmed Inc | PAVM:US | $13M | $112,000 | 450.00% |
| 42 | Scienture Holdings, Inc. | SCNX:US | $5M | $821,315 | 449.10% |
| 43 | Hydreight Technologies Inc | NURS:V | $167M | $78M | 421.40% |
| 44 | Altimmune Inc | ALT:US | $405M | $31,000 | 420.00% |
| 45 | Surrozen Inc | SRZN:US | $542M | $12M | 408.60% |
| 46 | Mesoblast Ltd | MESO:US | $1.9B | $120M | 390.70% |
| 47 | Apollomics Inc. Class A Ordinary Shares | APLM:US | $53M | $9M | 380.80% |
| 48 | MacroGenics Inc | MGNX:US | $149M | $175M | 378.00% |
| 49 | Nyxoah | NYXH:US | $86M | $29M | 365.00% |
| 50 | Pulse Biosciences Inc | PLSE:US | $3.9B | $1M | 359.30% |
| 51 | Pharmacielo Ltd | PCLO:V | $11M | $4M | 331.00% |
| 52 | Agios Pharm | AGIO:US | $1.9B | $141M | 330.00% |
| 53 | Monte Rosa Therapeutics Inc | GLUE:US | $903M | $70M | 325.80% |
| 54 | YD Bio Ltd | YDES:US | $475M | $1M | 314.90% |
| 55 | Kazia Therapeutics Ltd ADR | KZIA:US | $85M | $2M | 312.40% |
| 56 | MedMira Inc | MIR:V | $35M | $370,568 | 308.00% |
| 57 | Sinovac Biotech Ltd | SVA:US | $642M | $511M | 303.70% |
| 58 | Atea Pharmaceuticals Inc | AVIR:US | $346M | $192M | 295.20% |
| 59 | Insmed Inc | INSM:US | $25.5B | $1.5B | 268.40% |
| 60 | Alpha Cognition Inc | ACOG:US | $181M | $15M | 267.60% |
| 61 | Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | CUPR:US | $14M | $49,894 | 267.40% |
| 62 | Recursion Pharmaceuticals Inc | RXRX:US | $2.2B | $68M | 258.50% |
| 63 | INmune Bio Inc | INMB:US | $35M | - | 257.10% |
| 64 | MediciNova Inc | MNOV:US | $72M | $920,481 | 240.60% |
| 65 | Clene Inc. | CLNN:US | $57M | $197,000 | 233.30% |
| 66 | Editas Medicine Inc | EDIT:US | $395M | $47M | 232.30% |
| 67 | UroGen Pharma Ltd | URGN:US | $1.2B | $250M | 223.90% |
| 68 | Dianthus Therapeutics Inc. | DNTH:US | $5.1B | $3M | 205.60% |
| 69 | SINTX Technologies Inc | SINT:US | $12M | $1M | 199.30% |
| 70 | Silence Therapeutics PLC | SLN:US | $1.2B | $615,000 | 197.20% |
| 71 | BridgeBio Pharma Inc | BBIO:US | $15.2B | $946M | 192.60% |
| 72 | Bicycle Therapeutics Ltd | BCYC:US | $264M | $84M | 190.20% |
| 73 | Keros Therapeutics Inc | KROS:US | $184M | $41M | 180.50% |
| 74 | Adlai Nortye Ltd. American Depositary Shares | ANL:US | $718M | $18M | 178.10% |
| 75 | Taysha Gene Therapies Inc | TSHA:US | $1.4B | $5M | 171.30% |
| 76 | Arrowhead Pharmaceuticals Inc | ARWR:US | $6.9B | $669M | 171.00% |
| 77 | Avricore Health Inc | AVCR:V | $6M | $193,041 | 170.40% |
| 78 | Cue Biopharma | CUE:US | $146M | $38M | 166.70% |
| 79 | Healthcare Triangle Inc | HCTI:US | $3M | $26M | 158.40% |
| 80 | Eton Pharmaceuticals Inc | ETON:US | $1.9B | $141M | 157.90% |
| 81 | CorMedix Inc | CRMD:US | $415M | $462M | 156.50% |
| 82 | CAMP4 THERAPEUTICS CORPORATION | CAMP:US | $294M | $5M | 138.90% |
| 83 | ATAI Life Sciences BV | ATAI:US | $2.7B | $4M | 137.00% |
| 84 | Xilio Development Inc | XLO:US | $57M | $64M | 131.20% |
| 85 | Tenon Medical Inc | TNON:US | $4M | $5M | 126.80% |
| 86 | ProQR Therapeutics BV | PRQR:US | $191M | $18M | 120.40% |
| 87 | Autolus Therapeutics Ltd | AUTL:US | $351M | $117M | 118.40% |
| 88 | Senseonics Holdings, Inc. Common Stock | SENS:US | $454M | $49M | 117.80% |
| 89 | RenovoRx Inc | RNXT:US | $55M | $2M | 115.40% |
| 90 | Ascendis Pharma AS | ASND:US | $16.9B | $1.0B | 114.70% |
| 91 | Verastem Inc | VSTM:US | $1.1B | $100M | 113.60% |
| 92 | Foghorn Therapeutics Inc | FHTX:US | $111M | $37M | 112.70% |
| 93 | Aktis Oncology, Inc. Common stock | AKTS:US | $880M | $10M | 111.40% |
| 94 | Compugen | CGEN:US | $186M | $74M | 107.00% |
| 95 | Freenome, Inc. Common stock | FRNM:US | $1.1B | $35M | 106.50% |
| 96 | ABVC Biopharma Inc | ABVC:US | $26M | $797,916 | 104.50% |
| 97 | LSL Pharma Group Inc. | LSL:V | $39M | $42M | 102.70% |
| 98 | Biosyent Inc. | RX:V | $199M | $56M | 95.20% |
| 99 | Immunitybio Inc | IBRX:US | $9.2B | $166M | 93.90% |
| 100 | Immatics NV | IMTX:US | $979M | $42M | 93.00% |
| 101 | Reliq Health Technologies Inc | RHT:V | $47M | $15M | 88.50% |
| 102 | OneMedNet Corp. | ONMD:US | $35M | $1M | 88.40% |
| 103 | Fennec Pharmaceuticals Inc | FENC:US | $344M | $59M | 85.20% |
| 104 | Fennec Pharmaceuticals Inc | FRX:TO | $466M | $59M | 85.20% |
| 105 | SeaStar Medical Holding Corporation | ICU:US | $10M | $2M | 82.00% |
| 106 | Syndax Pharmaceuticals Inc | SNDX:US | $859M | $290M | 81.60% |
| 107 | Numinus Wellness Inc | NUMI:TO | $16M | $6M | 81.60% |
| 108 | Iovance Biotherapeutics Inc | IOVA:US | $3.7B | $379M | 80.10% |
| 109 | Rhythm Pharmaceuticals Inc | RYTM:US | $7.8B | $281M | 79.60% |
| 110 | OmniAb Inc. | OABI:US | $773M | $40M | 78.30% |
| 111 | Aclarion Inc | ACON:US | $5M | $98,560 | 78.10% |
| 112 | Personalis Inc | PSNL:US | $1.7B | $81M | 76.60% |
| 113 | Sera Prognostics Inc | SERA:US | $87M | $70,000 | 76.50% |
| 114 | Adagio Medical Holdings, Inc Common Stock | ADGM:US | $2M | $137,000 | 75.60% |
| 115 | Cronos Group Inc | CRON:US | $1.3B | $206M | 74.60% |
| 116 | Cronos Group Inc | CRON:TO | $1.8B | $206M | 74.60% |
| 117 | Innovative Eyewear Inc. | LUCY:US | $7M | $3M | 74.50% |
| 118 | Anbio Biotechnology Class A Ordinary Shares | NNNN:US | $179M | $9M | 73.90% |
| 119 | Wave Life Sciences Ltd | WVE:US | $664M | $71M | 73.00% |
| 120 | Icecure Medical | ICCM:US | $3M | $4M | 72.80% |
| 121 | Phathom Pharmaceuticals Inc | PHAT:US | $433M | $275M | 71.10% |
| 122 | TG Therapeutics Inc | TGTX:US | $9.2B | $800M | 70.30% |
| 123 | BGM Group Ltd. | BGM:US | $110M | $48M | 69.80% |
| 124 | Aequus Pharmaceuticals Inc | AQS:V | $1M | $918,468 | 69.70% |
| 125 | PTC Therapeutics Inc | PTCT:US | $5.4B | $1.2B | 69.60% |
| 126 | Alamar Biosciences, Inc. Common Stock | ALMR:US | $1.9B | $114M | 68.50% |
| 127 | Capstone Holding Corp. Common Stock | CAPS:US | $2M | $60M | 67.10% |
| 128 | BillionToOne, Inc. Class A Common Stock | BLLN:US | $5.5B | $397M | 64.40% |
| 129 | Corcept Therapeutics Incorporated | CORT:US | $8.2B | $964M | 64.00% |
| 130 | Tarsus Pharmaceuticals Inc | TARS:US | $3.4B | $682M | 63.90% |
| 131 | Anteris Technologies Global Corp. Common Stock | AVR:US | $579M | $2M | 63.30% |
| 132 | X4 Pharmaceuticals Inc | XFOR:US | $340M | $17M | 63.10% |
| 133 | Basel Medical Group Ltd Ordinary Shares | BMGL:US | $72M | $22M | 63.00% |
| 134 | VentriPoint Diagnostics Ltd | VPT:V | $14M | $147,773 | 61.70% |
| 135 | Kestra Medical Technologies, Ltd. Common Stock | KMTS:US | $1.7B | $107M | 59.90% |
| 136 | Sonoma Pharmaceuticals Inc | SNOA:US | $5M | $22M | 59.60% |
| 137 | Crescita Therapeutics Inc | CTX:TO | $15M | $23M | 59.40% |
| 138 | Redhill Biopharma Ltd | RDHL:US | $4M | - | 58.60% |
| 139 | Kiniksa Pharmaceuticals Ltd | KNSA:US | $7.8B | $946M | 58.10% |
| 140 | Carlsmed, Inc. | CARL:US | $438M | $63M | 56.70% |
| 141 | Star Equity Holdings Prf | STRRP:US | - | $210M | 54.60% |
| 142 | Star Equity Holdings Inc | STRR:US | $34M | $210M | 54.60% |
| 143 | Clover Health Investments Corp | CLOV:US | $2.6B | $2.7B | 53.10% |
| 144 | Carespan Health Inc | CSPN:V | $1M | $-145,310 | 53.10% |
| 145 | Avita Medical Ltd | RCEL:US | $521M | $85M | 53.10% |
| 146 | argenx NV ADR | ARGX:US | $58.3B | $5.9B | 52.10% |
| 147 | Pulsenmore Ltd. Ordinary Shares | PLSM:US | $10M | - | 52.00% |
| 148 | Legend Biotech Corp | LEGN:US | $4.6B | $1.3B | 51.90% |
| 149 | Axsome Therapeutics Inc | AXSM:US | $7.0B | $865M | 51.90% |
| 150 | Madrigal Pharmaceuticals Inc | MDGL:US | $9.3B | $1.4B | 50.10% |
| 151 | iTonic Holdings Ltd. | ITOC:US | $13M | $556,430 | 49.50% |
| 152 | OrganiGram Holdings Inc | OGI:TO | $175M | $309M | 49.40% |
| 153 | OrganiGram Holdings Inc | OGI:US | $126M | $309M | 49.40% |
| 154 | Coya Therapeutics, Inc. Common Stock | COYA:US | $78M | $8M | 49.00% |
| 155 | Gelteq Limited Ordinary Shares | GELS:US | $5M | $471,799 | 48.90% |
| 156 | Heartflow, Inc. Common Stock | HTFL:US | $4.6B | $212M | 47.60% |
| 157 | Arcutis Biotherapeutics Inc | ARQT:US | $3.2B | $509M | 45.10% |
| 158 | Zevra Therapeutics Inc. | ZVRA:US | $722M | $148M | 44.90% |
| 159 | Hyperfine Inc | HYPR:US | $76M | $17M | 44.80% |
| 160 | Xeris Pharmaceuticals Inc | XERS:US | $2.9B | $368M | 44.20% |
| 161 | Extendicare Inc | EXE:TO | $2.6B | $2.2B | 42.60% |
| 162 | Precision Optics Corporation, Inc. Common stock | POCI:US | $55M | $32M | 42.00% |
| 163 | Neurocrine Biosciences Inc | NBIX:US | $17.1B | $3.7B | 41.20% |
| 164 | TransMedics Group Inc | TMDX:US | $3.3B | $728M | 41.10% |
| 165 | Prelude Therapeutics Inc | PRLD:US | $300M | $22M | 41.00% |
| 166 | Uniqure NV | QURE:US | $1.6B | $20M | 40.40% |
| 167 | Mirum Pharmaceuticals Inc | MIRM:US | $6.1B | $671M | 39.60% |
| 168 | Coherus BioSciences Inc | CHRS:US | $119M | $51M | 39.50% |
| 169 | SS Innovations International Inc. Common Stock | SSII:US | $375M | $52M | 39.40% |
| 170 | CareDx Inc | CDNA:US | $4.1B | $497M | 39.30% |
| 171 | Halozyme Therapeutics Inc | HALO:US | $11.7B | $1.8B | 39.20% |
| 172 | Assembly Biosciences Inc | ASMB:US | $416M | $75M | 38.90% |
| 173 | Nano X Imaging Ltd | NNOX:US | $18M | $16M | 36.70% |
| 174 | Alignment Healthcare LLC | ALHC:US | $1.5B | $4.9B | 36.70% |
| 175 | Kyntra Bio, Inc. | KYNB:US | $15M | $5M | 36.50% |
| 176 | 20/20 Biolabs, Inc. Common Stock | AIDX:US | $3M | $2M | 36.50% |
| 177 | Kura Oncology Inc | KURA:US | $647M | $77M | 36.50% |
| 178 | Clearpoint Neuro Inc | CLPT:US | $276M | $45M | 36.30% |
| 179 | Regeneron Pharmaceuticals Inc | REGN:US | $93.6B | $16.9B | 36.30% |
| 180 | Travere Therapeutics Inc | TVTX:US | $4.8B | $651M | 36.20% |
| 181 | Guardant Health Inc | GH:US | $21.5B | $1.3B | 36.10% |
| 182 | Intelligent Bio Solutions Inc. | INBS:US | $8M | $4M | 35.80% |
| 183 | Brainsway Ltd | BWAY:US | $449M | $61M | 35.40% |
| 184 | Humacyte Inc | HUMA:US | $125M | $2M | 34.90% |
| 185 | Vivos Therapeutics Inc | VVOS:US | $3M | $21M | 34.90% |
| 186 | Quanterix Corp | QTRX:US | $160M | $153M | 34.40% |
| 187 | Omada Health, Inc. Common Stock | OMDA:US | $936M | $333M | 34.20% |
| 188 | Natera Inc | NTRA:US | $45.0B | $2.9B | 34.10% |
| 189 | Establishment Labs Holdings Inc | ESTA:US | $2.0B | $264M | 33.90% |
| 190 | BeOne Medicines AG | ONC:US | $47.7B | $6.6B | 33.80% |
| 191 | MedX Health Corp | MDX:V | $13M | $569,792 | 33.70% |
| 192 | Vitalhub Corp | VHI:TO | $495M | $127M | 33.00% |
| 193 | Biofrontera Inc | BFRI:US | $12M | $46M | 32.90% |
| 194 | Voyageur Pharmaceuticals Ltd | VM:V | $27M | $50,854 | 32.70% |
| 195 | Pennant Group Inc | PNTG:US | $1.3B | $1.2B | 32.00% |
| 196 | Quipt Home Medical Corp. | QIPT:TO | $221M | $265M | 32.00% |
| 197 | Biomarin Pharmaceutical Inc | BMRN:US | $10.9B | $3.7B | 32.00% |
| 198 | Universal Ibogaine Inc | IBO:V | $2M | $2M | 30.60% |
| 199 | Beta Bionics, Inc. Common Stock | BBNX:US | $854M | $127M | 30.30% |
| 200 | Krystal Biotech Inc | KRYS:US | $8.9B | $470M | 30.20% |
Frequently Asked Questions
Which Canadian company ranks #1 by revenue growth (yoy) in Health Care?
As of November 11, 2026, Axe Compute Inc. (AGPU:US) ranks #1 in Health Care at 119772.90%.
How often is this ranking updated?
The table is rebuilt from live fundamentals throughout the day. This page currently shows data as of November 11, 2026.
How many companies are in this revenue growth (yoy) list?
This view shows 200 Canadian listings in Health Care. Canadian Depositary Receipts are hidden by default.
What is the difference between TSX and TSXV?
The Toronto Stock Exchange (TSX) lists larger established companies. The TSX Venture Exchange (TSXV) lists earlier-stage companies. Use the exchange filter to separate them.
Explore More Stock Rankings
Largest by Market Cap
Companies with the highest market capitalization
Largest by Revenue
Companies with the highest annual revenue
Highest Profit Margin
Most profitable companies by net margin
Highest Return on Equity
Companies generating the best returns for shareholders
Highest Return on Assets
Most efficient companies at using assets
Highest Dividend Yield
Top dividend-paying stocks
Fastest Earnings Growth
Companies with strongest year-over-year earnings growth